EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dictamnine Exhibits Anti-Asthmatic Effects by Modulating TGF-β/Smad2/3 Signaling in a Murine Asthma Model and Human Bronchial Epithelial Cells

Myung-A Jung iD, Bu-Yeo Kim, Joo Young Lee iD, Kon-Young Ji iD, Mi Han Lee, Dong Ho Jung iD, Mudan Cai, Taesoo Kim iD

International Journal of Molecular Sciences · 10.12.2025 · 26 (24) · 11891

DOI: 10.3390/ijms262411891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.12.2025. Verfasst von Myung-A Jung und 7 weiteren Autor:innen. Beteiligte Einrichtung: KM Convergence Research Division, Korean Institute of Oriental Medicine, Daejeon 34054, Republic of Korea. Hauptthemen laut MEDLINE: Asthma, Transforming Growth Factor beta, Smad2 Protein, Smad3 Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Oriental Medicine, Korean Institute of Oriental Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current asthma therapies reduce inflammation and symptoms but there are concerns regarding adverse effects and the long-term treatment burden. The anti-asthmatic potential of Dictamnine (Dic) has not been investigated. The therapeutic effect of Dic on airway inflammation and remodeling was investigated by targeting the tumor growth factor (TGF)-β/Smad2/3 pathway. A murine model of ovalbumin (OVA)-induced asthma was used to evaluate the effects of orally-administered Dic on airway hyperresponsiveness, inflammatory cytokines in bronchoalveolar lavage fluid (BALF), OVA-specific IgE in the serum, and histopathological changes. The expression of TGF-β/Smad2/3 and epithelial markers was assessed. Human bronchial epithelial cells were used in vitro to examine the effects of Dic on TGF-β-induced Smad2/3 phosphorylation. Network pharmacology was conducted to predict Dic-associated targets and pathways. Dic substantially reduced the levels of Th2 cytokines, mucin 5AC in BALF, and OVA-specific IgE in the serum. Histology indicated reduced inflammatory cell infiltration, bronchial wall thickening, and peribronchial fibrosis in Dic-treated mice. Dic downregulated TGF-β and p-Smad2/3 expression and upregulated ZO-1 expression in the lung tissue. Dic downregulated TGF-β-induced Smad2/3 phosphorylation in bronchial epithelial cells. Network pharmacology indicated enrichment of Dic-related genes in the TGF-β pathway. Dic exhibited anti-asthmatic effects and is a potential therapeutic candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaTransforming Growth Factor betaSmad2 ProteinSmad3 ProteinSignal TransductionAnti-Asthmatic AgentsEpithelial CellsDioxolesAnimalsHumansMiceDisease Models, AnimalBronchiOvalbuminCytokinesMice, Inbred BALB CBronchoalveolar Lavage FluidImmunoglobulin EFemalePhosphorylationIsoquinolinesPyridinesPyrroles

Stichwörter der Autor:innen

TGF-β/Smad2/3airway inflammationallergic asthmaanti-asthmaticdictamnineepithelial integrity

Substanzen

Transforming Growth Factor betaSmad2 ProteinSmad3 ProteinAnti-Asthmatic Agents6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hyd…OvalbuminCytokinesDioxolesImmunoglobulin ESmad3 protein, mouse

Autor:innen und Institutionen

  • KM Convergence Research Division, Korean Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
  • Research Infrastructure Team, R&D Strategy Division, Korean Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
  • KM Science Research Division, Korean Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.

ORCID-Profile: Myung-A Jung, Joo Young Lee, Kon-Young Ji, Dong Ho Jung, Taesoo Kim

Förderung

  • Korea Institute of Oriental Medicine
  • Korean Institute of Oriental Medicine

Zitieren

APA

Jung, M. A., Kim, B. Y., Lee, J. Y., Ji, K. Y., Lee, M. H., Jung, D. H., Cai, M., & Kim, T. (2025). Dictamnine Exhibits Anti-Asthmatic Effects by Modulating TGF-β/Smad2/3 Signaling in a Murine Asthma Model and Human Bronchial Epithelial Cells. International Journal of Molecular Sciences, 26(24), 11891. https://doi.org/10.3390/ijms262411891

Vancouver

Jung MA, Kim BY, Lee JY, Ji KY, Lee MH, Jung DH, et al. Dictamnine Exhibits Anti-Asthmatic Effects by Modulating TGF-β/Smad2/3 Signaling in a Murine Asthma Model and Human Bronchial Epithelial Cells. International Journal of Molecular Sciences. 2025;26(24):11891. doi:10.3390/ijms262411891

BibTeX
@article{Jung2025,
  author = {Jung, Myung-A and Kim, Bu-Yeo and Lee, Joo Young and Ji, Kon-Young and Lee, Mi Han and Jung, Dong Ho and Cai, Mudan and Kim, Taesoo},
  title = {Dictamnine Exhibits Anti-Asthmatic Effects by Modulating TGF-β/Smad2/3 Signaling in a Murine Asthma Model and Human Bronchial Epithelial Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {11891},
  doi = {10.3390/ijms262411891}
}
Kostenlos starten →